Answers are grounded in this paper and cite their sources.
In our experience, Angioseal™ may be a safe and off-label effective closure device for patients undergoing DCP for neuroendovascular procedures. It obviates the need for manual compression without causing any structural or hemodynamic changes within the carotid artery. Larger studies with longer follow-up are required to establish its safety in patients undergoing DCP.
No takes yet. Share an insight, caveat, or question.
Cuellar et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: